Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-242468
Filing Date
2005-12-14
Accepted
2005-12-14 14:57:18
Documents
10
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 935141
2 RESTATED CERTIFICATE OF INCORPORATION OF REGISTRANT, AS AMENDED dex34.htm EX-3.4 111488
3 COLLABORATIVE RESEARCH AND LICENSING AGREEMENT dex10148.htm EX-10.148 160392
4 FORM OF INDEMNIFICATION AGREEMENT dex10149.htm EX-10.149 49862
5 LIST OF SUBSIDIARIES dex21.htm EX-21 2243
6 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 2457
7 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 10337
8 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 10374
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 3188
10 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 3208
  Complete submission text file 0001193125-05-242468.txt   1290182
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 6178618444
INDEVUS PHARMACEUTICALS INC (Filer) CIK: 0000854222 (see all company filings)

EIN.: 043047911 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-18728 | Film No.: 051263626
SIC: 2834 Pharmaceutical Preparations